AYTU vs TKNO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AYTU Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Growth & Margin while TKNO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, AYTU trades at 9.2x Forward P/E with -14.4% operating margin (+6.4% YoY revenue) versus TKNO at N/M Forward P/E and -31.6% operating margin (+21.5% YoY). In options structure, AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TKNO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AYTU | TKNO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | $521.8M | Larger Scale | TKNO |
| Trailing P/E Ratio Valuation | 9.2x | N/M | Lower Multiple | AYTU |
| Forward P/E Ratio Valuation | 9.2x | N/M | Lower Multiple | AYTU |
| Revenue Growth (YoY) Growth | +6.4% | +21.5% | Higher Growth | TKNO |
| Operating Margin (TTM) Profitability | -14.4% | -31.6% | Higher Margin | AYTU |
| Net Profit Margin Profitability | -24.8% | -34.8% | Higher Margin | AYTU |
| Return on Equity (ROE) Capital Efficiency | -52.5% | -24.1% | Higher ROE | TKNO |
| 52-Week Range Position Momentum | 5% ($2โ$3) | 79% ($2โ$9) | Stronger Trend | TKNO |
| Beta / 30D Volatility Risk Regime | 0.65ฮฒ ยท 35% Vol | 1.19ฮฒ ยท 114% Vol | Lower Realized Risk | AYTU |
| Unified Institutional Score Composite Signal | 48.9 / 100 (HOLD) | 37.6 / 100 (SELL) | Higher Composite | AYTU |